Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals
<p>Abstract</p> <p>Background</p> <p>The first line anti-tuberculosis drugs isoniazid (INH), rifampicin (RIF) and pyrazinamide (PZA) continues to be the effective drugs in the treatment of tuberculosis, however, the use of these drugs is associated with toxic reactions...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2008-07-01
|
| Series: | Nutrition & Metabolism |
| Online Access: | http://www.nutritionandmetabolism.com/content/5/1/18 |